Skip to content
Open access

Early Body-Composition Trajectory During Tirzepatide Treatment for Obesity: A Real-World Bioimpedance Cohort Study

Oct 2026 · Journal of Clinical Medicine · Vol 15, pp. 8377 · 0 citations · 64 references

TL;DR

Early weight loss during tirzepatide treatment was predominantly fat mass, with a BIA-derived FFM fraction numerically close to the commonly cited one-fourth.

Abstract

Background/Objectives: Whether the loss of fat-free mass (FFM) during tirzepatide treatment exceeds the proportion expected in negative energy balance is debated, and the earliest weeks of treatment are the least characterized. We described the body-composition trajectory over the first 12 weeks of treatment in routine care. Methods: In this retrospective cohort of adults with obesity starting tirzepatide monotherapy, body weight, fat mass, FFM, total body water (TBW), and waist circumference were measured by single-frequency, foot-to-foot bioelectrical impedance analysis (BIA) at baseline and at approximately 4, 8, and 12 weeks, and were analyzed with linear mixed-effects models; follow-up values are available-data, on-treatment estimates. Results: Of 476 patients (mean age 40 years, 66% female, mean body-mass index 38.7 kg/m2), 268 had follow-up data and 111 were measured at 12 weeks. Estimated marginal body weight fell by 11.22 kg (10.4%), fat mass by 7.90 kg (16.8%), and BIA-derived FFM by 3.35 kg (5.4%) at 12 weeks (all p < 0.001); assuming 5-kg-less loss in patients without a 12-week measurement, the mean loss remained 7.4 kg. Of patients measured at 12 weeks, 89.2% had lost at least 5% and 57.7% at least 10% of body weight. In patients with complete data at baseline and 12 weeks (n = 85), fat mass accounted for 68.3% (95% CI 56.1 to 80.8) of the weight lost. Conclusions: Early weight loss during tirzepatide treatment was predominantly fat mass, with a BIA-derived FFM fraction numerically close to the commonly cited one-fourth. Because device-FFM equaled TBW divided by a fixed coefficient of 0.731 at every visit, it cannot separate water from lean tissue and is best read as an upper bound on lean tissue loss rather than a measure of muscle.

Read PDF

Similar papers

Open access Oct 2026

Temporal Changes in Anthropometric Circumferences and Bioimpedance-Derived Body Composition During Eight Weeks of Reformer Pilates in Young Women Without Regular Exercise Participation

Background: Evidence on Pilates-related body composition is inconsistent, and few studies track changes during programs. Objective: To assess body mass, bioimpedance-derived body-fat percentage and muscle mass, and seven circumferences at baseline, week 4, and week 8 of supervised Reformer Pilates. Methods: Twenty-two...

Hüseyin Aslan, Musa Şahin, Meltem Çayirli et al. · 0 citations
Open access Sep 2026

Real-world effectiveness of 6-month tirzepatide therapy on body weight and composition in adults with overweight and obesity.

AIMS/HYPOTHESIS Obesity drives cardiometabolic dysfunction and increases cardiovascular risk, with excess fat mass and impaired body composition playing a key role in metabolic outcomes. This clinical study aimed to evaluate the real-world effectiveness (RWE) of tirzepatide on body weight, body composition, and metabol...

Davide Brancato, V. Maggio, Francesca Vaccaro et al. · 0 citations
Open access Oct 2026

Body Composition and Quality of Weight Loss During Liraglutide 3.0 mg Therapy: Association with a Structured Exercise Programme

Background/Objectives: We evaluated changes in body composition, metabolic parameters, and quality of life during liraglutide 3.0 mg treatment within a multimodal obesity-management programme and explored their association with participation in structured exercise. Methods: This prospective, non-randomised, real-world...

M. Maćešić, Filip Radovic, J. Zekovic et al. · 0 citations
Sep 2026

Changes in Body Composition Assessed by Bioelectrical Impedance Analysis in Patients Treated with GLP-1 Receptor Agonists: A Real-World Experience.

OBJECTIVE Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) induce significant weight loss in patients with obesity; however, data on real-world body composition changes are limited. METHODS We conducted a retrospective real-world observational study including 388 obese adults treated with GLP-1 RAs and followed...

J. Goñi, M. S. Barba, G. López et al. · 0 citations
Open access Oct 2026

Body Weight Changes and Exploratory Metabolic Outcomes During Semaglutide and Tirzepatide Treatment: A Real-World Longitudinal Cohort Study from Türkiye

Both semaglutide and tirzepatide were associated with early reductions in body weight, and the month 6 estimate for this group relied primarily on the model and requires cautious interpretation.

E. Çokiçli, Murat Kayır, Alp Russell Abbasoglu et al. · 0 citations
Oct 2026

Bioimpedance-Derived Hydration and Body Composition Shifts Across Ramadan in Competitive Swimmers Aged 6-20 Years: A Prospective Cohort Study.

Ramadan fasting can alter hydration, sleep, and training schedules in competitive swimmers aged 6-20 years, but evidence in swimmers is limited. This prospective cohort study investigated within-participant changes in bioelectrical impedance analysis and body composition across Ramadan in swimmers. Swimmers were assess...

Ana Anjos, Étienne Gouraud, Mohammed Al Musaabi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.